. 2023 Jun 28;81(3):579–591. doi: 10.1007/s12020-023-03422-7

Table 3.

Mineral content of L4 and femora performed 18 weeks after Orx in Non-Orx rats and Orx rats either untreated or treated with ostarine or testosterone

Group	Non-Orx		Orx		Ostarine Therapy		Ostarine Proph.		Test Therapy		Test Proph.
	Mean	SD	Mean	SD	Mean	SD	Mean	SD	Mean	SD	Mean	SD
L4
Calcium [%]	36.41	1.19	35.88	0.53	36.20	0.49	36.09	0.84	36.31	0.75	36.00	0.27
Magnesium [%]	0.72	0.03	0.70	0.03	0.70	0.04	0.69	0.03	0.67	0.04	0.70	0.02
Phosphate [%]	63.6	2.2	62.6	1.5	63.7	1.4	64.2	1.5	64.2	1.8	64.4	0.57
Ca/PO₄	0.77	0.02	0.78	0.01	0.77	0.01	0.76	0.01	0.77	0.01	0.75^a,b	0.004
Mineral content [%]	31.3	1.7	27.8^a	2.9	30.5	3.0	31.4^b	1.9	28.4	1.8	29.1	1.2
Femora
Calcium [%]	35.28	0.89	35.13	1.39	35.69	0.67	35.70	0.49	35.21	0.62	35.88	0.39
Magnesium [%]	0.52	0.04	0.52	0.05	0.54	0.03	0.56	0.04	0.56	0.03	0.63^a,b,c,d,e	0.01
Phosphate [%]	54.9	1.5	54.6	2.3	55.3	1.4	56.1	0.6	54.8	1.2	56.0	1.0
Ca/PO₄	1.52	0.01	1.53	0.02	1.53	0.02	1.51	0.01	1.52	0.02	1.52	0.01
Mineral content [%]	45.8	6.3	39.7^a	2.7	41.3	1.9	36.6^a	3.7	39.4	3.9	40.6	1.9

^aDiffers from Non-Orx, ^bdiffers from Orx, ^cdiffers from Ostarine Therapy group, ^ddiffers from Ostarine Proph. group, ^ediffers from Test. Therapy group, (p > 0.05, Tukey-test)